Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  JAMA Neurology

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jamaneurol.2013.4646PMID 24145899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects

  2013cited by this paper
• Eosinophil-Derived Neurotoxin Is Elevated in Patients with Amyotrophic Lateral Sclerosis

  2013cited by this paper
• Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression

  2012cited by this paper
• Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS

  2012cited by this paper
• Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

  2011cited by this paper
• H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China

  2011cited by this paper
• Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.

  2011cited by this paper
• Repertoire of microglial and macrophage responses after spinal cord injury

  2011cited by this paper
• Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations

  2011cited by this paper
• Plasma biomarkers associated with ALS and their relationship to iron homeostasis

  2010cited by this paper
• Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Biology of interleukin-10.

  2010cited by this paper
• CSF glial markers correlate with survival in amyotrophic lateral sclerosis

  2010cited by this paper
• Biomarkers in amyotrophic lateral sclerosis.

  2009cited by this paper
• Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis

  2009cited by this paper
• A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis

  2009cited by this paper
• Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

  2008cited by this paper
• The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population.

  2007cited by this paper
• RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis

  2007cited by this paper
• Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis.

  2007cited by this paper
• Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype

  2007cited by this paper
• Axonal damage markers in cerebrospinal fluid are increased in ALS

  2006cited by this paper
• Intrathecal Upregulation of Granulocyte Colony Stimulating Factor and Its Neuroprotective Actions on Motor Neurons in Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS

  2006cited by this paper
• HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin

  2006cited by this paper
• Production of monocyte chemoattractant protein‐1 in amyotrophic lateral sclerosis

  2005cited by this paper
• Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS

  2005cited by this paper
• Individual survival time prediction using statistical models

  2005cited by this paper
• Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?

  2005cited by this paper
• Elevated IL-6 and TNF-α levels in patients with ALS: Inflammation or hypoxia?

  2005cited by this paper
• Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences.

  2004cited by this paper
• Plasma amino acids percentages in amyotrophic lateral sclerosis patients

  2003cited by this paper
• Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

  2003cited by this paper
• Increased red blood cell polyamines in ALS and Parkinson's disease.

  2002cited by this paper
• Increased plasma TGF‐β1 in patients with amyotrophic lateral sclerosis

  2002cited by this paper
• Cardiac papillary fibroelastoma: an unusual source of cerebral embolism solved with local fibrinolysis

  2002cited by this paper
• Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis.

  2001cited by this paper
• El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis

  2000cited by this paper
• The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

  1999cited by this paper
• Cellular distribution of ferritin subunits in postnatal rat brain

  1998cited by this paper
• Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

  1996cited by this paper
• Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis

  1993cited by this paper
• Free amino acid levels in amyotrophic lateral sclerosis

  1978cited by this paper
• Computation of a Best Subset in Multivariate Analysis

  1978cited by this paper
• Chapter 3 – Plasma Amino Acids

  1970cited by this paper
• CLINICAL NEUROSCIENCE: GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis

  year unknowncited by this paper

• Amyotrophic Lateral Sclerosis (ALS) Genetics and Microbiota: A Comprehensive Review.

  2026cites this paper
• Neuroinflammation and Amyotrophic Lateral Sclerosis: Recent Advances in Anti-Inflammatory Cytokines as Therapeutic Strategies

  2025cites this paper
• The critical role of iron homeostasis in neurodegenerative diseases

  2025cites this paper
• Elevated Serum MCP‐2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients

  2025cites this paper
• Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis

  2024cites this paper
• Prognostic communication in amyotrophic lateral sclerosis: findings from a Nationwide Italian survey

  2024cites this paper
• The multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology.

  2024influential citation
• Development and validation of a novel combinational index of liquid biopsy biomarker for longitudinal lung cancer patient management

  2024cites this paper
• Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis

  2023cites this paper
• Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis

  2022cites this paper
• Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets

  2022cites this paper
• Whole and fractionated human platelet lysate biomaterials-based biotherapy induces strong neuroprotection in experimental models of amyotrophic lateral sclerosis.

  2021cites this paper
• Normal aging, motor neurone disease, and Alzheimer’s disease are characterized by cortical changes in inflammatory cytokines

  2021cites this paper
• Amyotrophic Lateral Sclerosis (ALS) prediction model derived from plasma and CSF biomarkers

  2021cites this paper
• A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications.

  2020cites this paper
• IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis

  2020cites this paper
• Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis

  2020cites this paper
• Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

  2020cites this paper
• Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis

  2019cites this paper
• Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?

  2019cites this paper
• Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?

  2019cites this paper
• Machine learning methods for MRI biomarkers analysis of pediatric posterior fossa tumors

  2019cites this paper
• A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis

  2019cites this paper
• Biomarkers of Blood–Brain Barrier Dysfunction

  2019cites this paper
• Increased Interleukin-6 Levels in the Astrocyte-Derived Exosomes of Sporadic Amyotrophic Lateral Sclerosis Patients

  2019cites this paper
• Longitudinal assessment of clinical and inflammatory markers in patients with amyotrophic lateral sclerosis.

  2018cites this paper
• Hereditary Motor Neuropathies and Amyotrophic Lateral Sclerosis: a Molecular and Clinical Update

  2018cites this paper
• Adipsin, MIP-1b, and IL-8 as CSF Biomarker Panels for ALS Diagnosis

  2018cites this paper
• Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach

  2018cites this paper
• Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis

  2018cites this paper
• Hepcidin, an emerging and important player in brain iron homeostasis

  2018influential citation
• Modulation of the inflammatory response in amyotrophic lateral sclerosis

  2018cites this paper
• Structural MRI correlates of amyotrophic lateral sclerosis progression

  2017cites this paper
• Cytokine expression levels in ALS: A potential link between inflammation and BMAA-triggered protein misfolding.

  2017cites this paper
• Evaluating the levels of CSF and serum factors in ALS

  2017cites this paper
• Biomarkers in Neurodegenerative Diseases.

  2017cites this paper
• Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients

  2017cites this paper
• Further development of biomarkers in amyotrophic lateral sclerosis

  2016cites this paper
• Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progression

  2016cites this paper
• Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis

  2016cites this paper
• Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism

  2016cites this paper
• IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1

  2016cites this paper
• Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis

  2016influential citation
• Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis

  2016cites this paper
• Emerging molecular biomarker targets for amyotrophic lateral sclerosis.

  2016cites this paper
• Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis

  2015cites this paper
• Serum ferritin is elevated in amyotrophic lateral sclerosis patients

  2015cites this paper
• Use of biomarkers in ALS drug development and clinical trials.

  2015cites this paper
• Biological follow‐up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis

  2015cites this paper
• Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study.

  2015cites this paper
• Humoral factors in ALS patients during disease progression

  2015cites this paper
• A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders

  2015cites this paper
• Ophthalmic Manifestations of Amyotrophic Lateral Sclerosis (An American Ophthalmological Society Thesis).

  2015cites this paper
• Outcome measures in amyotrophic lateral sclerosis clinical trials.

  2014cites this paper
• An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis

  2014cites this paper
• Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells.

  2014cites this paper
• Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research

  2014cites this paper
• Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis

  2014cites this paper
• Quantifying Disease Progression in Amyotrophic Lateral Sclerosis

  2014cites this paper